$APM

2 stories mentioning APMUpdated 27d ago

Every FINWIRES story that references APM, newest first.

Aptorum to Implement 1-for-10 Reverse Stock Split

Aptorum (APM) said Thursday it will implement a 1-for-10 reverse stock split of its issued and outstanding class A and class B ordinary shares in connection with its merger with DiamiR Biosciences, which is expected to close on or about Monday.The company will also redomicile to Delaware and change its name to Niki BioSolutions in connection with the merger. Aptorum said it expects its common stock to begin trading on the Nasdaq Capital Market under the ticker "NIKI" on Monday on a split-adjusted basis.Shares of Aptorum were down nearly 22% in Thursday trading.Price: $0.64, Change: $-0.18, Percent Change: -21.75%

$APM

Wire51d ago

Aptorum's Merger Target DiamiR Begins Alzheimer's Biomarker Study With AlzLabs

Aptorum Group (APM) said Monday its merger target, DiamiR Biosciences, is collaborating with AlzLabs Precision Diagnostics to evaluate blood-based biomarkers for Alzheimer's disease.The companies will generate protein and microRNA data from blood plasma samples collected from participants whose amyloid status was confirmed through amyloid PET imaging, according to a statement.The study will assess biomarker panels both on their own and in combination with DiamiR's CogniMIR technology, the companies said.Aptorum and DiamiR previously agreed to an all-stock merger under which DiamiR will become a wholly owned subsidiary of Aptorum and the combined company will operate as Niki BioSolutions, with its stock expected to trade under the ticker symbol NIKI.Shares of Aptorum were up more than 2% in Monday trading.Price: $0.85, Change: $+0.02, Percent Change: +2.19%

$APM

Track with the FINWIRES app suite

FolioX

Track APM in your portfolio

WheelAI

Analyze APM options with the wheel strategy

StockInsider

See market sentiment on APM